Robert Yoder
Corporate Officer/Principal presso TREVENA, INC.
Patrimonio netto: 73 083 $ in data 31/03/2024
Profilo
Robert T.
Yoder is currently the Chief Business Officer & Senior Vice President at Trevena, Inc. Prior to his current position, he worked as the Head of Information Technology at Orexigen Therapeutics, Inc. from 2015 to 2018.
Mr. Yoder holds an MBA from Emory University and an undergraduate degree from Dickinson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TREVENA, INC.
0.87% | 14/12/2023 | 158 877 ( 0.87% ) | 73 083 $ | 31/03/2024 |
Posizioni attive di Robert Yoder
| Società | Posizione | Inizio |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10/12/2018 |
Precedenti posizioni note di Robert Yoder
| Società | Posizione | Fine |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Formazione di Robert Yoder
| Emory University | Masters Business Admin |
| Dickinson College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Robert Yoder
